AbbVie
ABBV
#27
Rank
S$444.96 B
Marketcap
$251.91
Share price
0.28%
Change (1 day)
23.93%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of June 2024 : S$8.88 B

According to AbbVie's latest financial reports the company has S$8.88 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$S$13.73 B-40.75%
2022-12-31$S$23.17 B11.33%
2021-12-31$S$20.81 B20.23%
2020-12-31$S$17.31 B-257.57%
2019-12-31$-S$10.99 B-4.49%
2018-12-31$-S$11.51 B-268.77%
2017-12-31$S$6.81 B1.6%
2016-12-31$S$6.70 B20.13%
2015-12-31$S$5.58 B142.67%
2014-12-31$S$2.30 B-59.56%
2013-12-31$S$5.69 B38.32%
2012-12-31$S$4.11 B-73.37%
2011-12-31$S$15.45 B-23.64%
2010-12-31$S$20.23 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$114.59 B 1,189.77%๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.23 B 150.24%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.76 B 99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
S$7.71 B-13.14%๐Ÿ‡บ๐Ÿ‡ธ USA
S$23.70 B 166.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$20.69 B 132.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.69 B 155.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$51.57 B 480.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$3.26 B-63.21%๐Ÿ‡บ๐Ÿ‡ธ USA